IC information sheet can be used with IC waivers

August 2013
IRB Advisor;Aug2013, Vol. 13 Issue 8, p90
The article discusses the informed consent (IC) information as a useful tool in studies that are sensitive and when the Institutional Review Board (IRB) decides to have no names in study records. The consent document is the only link between the name of the study participants and the study with no signatures and names recorded if information sheet is used. IRB may require investigator to provide participants with a written statement about the research when documentation requirement is waived.


Related Articles

  • Assess your QI program and adjust according.  // Clinical Trials Administrator;Jul2011, Vol. 9 Issue 7, p81 

    The article discusses that research organizations assess and adjust their quality improvement (QI) and auditing programs to ensure compliance in human subjects research. An example of Winthrop University Hospital in Mineola, New York, is cited where evaluation of the QI program led to an...

  • Reviewing research on Mechanical Turk.  // IRB Advisor;Dec2010, Vol. 10 Issue 12, p140 

    The article discusses how institutional review boards (IRBs) should review research using Amazon's Mechanical Turk online service. According to Panos Ipeirotis, an associate professor at the Leonard N. Stern School of Business at New York University, several questions have been raised by IRBs on...

  • Seeking genetic review common ground.  // IRB Advisor;Jul2011, Vol. 11 Issue 7, p78 

    The article discusses key findings of a survey of genetic researchers and IRB professionals as a part of Genetic Research Review and Issues Project (GRRIP) to examine their attitudes about genetic research. The survey concluded that while both groups reported dealing with the same set of issues,...

  • Pre-review process results in faster IRB review process.  // IRB Advisor;8/1/2012, p89 

    The article focuses on the pre-review submissions in the Institutional Review Board (IRB) review process. It also discusses the IRB's additional research associate at the University of Tennessee Gradute School of Medicine (UTGSM) in Knoxville, pre-reviewing all prospective submissions and...

  • CNE/CME QUESTIONS.  // IRB Advisor;Dec2011, Vol. 11 Issue 12, p132 

    No abstract available.

  • IRB takes on readability with staff education.  // IRB Advisor;Feb2012, Vol. 12 Issue 2, p19 

    The article discusses how improving the readability of informed consent is a process requiring ongoing commitment. Hallie Kassan, director of the IRB office at the Feinstein Institute for Medical Research in Manhasset, New York says that the need to revisit something on which one educates in...

  • Audit toolbag puts focus on improvement.  // IRB Advisor;Mar2012, Vol. 12 Issue 3, p34 

    The article discusses an audit program used by Dana-Farber/Harvard Cancer Center (DF/HCC) to find areas in human subject's protection that need improvement. It mentions that the quality assurance (QA) auditing team has added two new review types in the program namely, targeted audits and risk...

  • Take steps now to reduce burden.  // IRB Advisor;Sep2012, Vol. 12 Issue 9, p103 

    The article discusses some of the steps that Institutional Review Boards (IRBs) can take to work within the current regulations and achieve the Department of Health and Human Service's (DHHS's) goals of lessening the burden on investigators and IRBs while still protecting subjects. Jeffrey...

  • VOICE offers model for thorough, subject-friendly consent process.  // IRB Advisor;Oct2012, Vol. 12 Issue 10, p109 

    The article discusses a new model the Valid Optimized Informed Consent Education (VOICE) program which addresses concerns about the readability of informed consent (IC) forms and participant comprehension during the IC process. The informed consent (IC) process is a critical process in any...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics